期刊文献+

肿瘤抑素抗肿瘤相关肽对肝癌细胞增殖和凋亡的影响 被引量:7

Effect of Tumstatin Anti-tumor Peptide on Proliferation and Apoptosis of Hepatocarcinoma Cell
下载PDF
导出
摘要 肿瘤抑素抗肿瘤相关肽-19肽是由肿瘤抑素185~203住氨基酸组成,具有直接抑制黑色素瘤细胞生长作用,但其对肝癌细胞增殖和凋亡是否有影响,对肝癌是否具有治疗作用还需进一步研究。本研究中采用基因工程技术将合成19肽基因与载体pTYB2重组后进行蛋白表达、纯化获得19肽。通过MTT法、生长曲线观察19肽对人肝癌细胞生长抑制作用;TUNEL标记法、流式细胞仪细胞周期检测法、透射电镜观察19肽对肝癌细胞凋亡的影响:小鼠H22腹水型转移型肝癌实体瘤抑瘤实验证明其体内的抑瘤作用。MTT实验和生长曲线实验表明随着19肽浓度的增加肝癌细胞的存活率下降。在相同19肽浓度下,随着作用时间延长存活细胞逐渐减少。电镜观察治疗组细胞出现明显凋亡,流式细胞仪可检测到前G1峰,TUNEL标记法也证实治疗组可见明显的凋亡细胞,体内19肽作用的小鼠H22腹水型转移型肝癌的抑瘤率达48.46%。可见,肿瘤抑素19肽可抑制肝癌细胞生长,促进肝癌细胞凋亡,对肝癌具有一定的治疗作用。 In this study, the basic sequences of 19peptide were synthesized and inserted into vector pTYB2. After being expressed and purified, the soluble 19peptide was obtained. The inhibiting effect on hepatocarcinoma cell was selected by 3-[4, 5-dimehyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide (MTT) assay and cell growth curve. The apoptosis index was observed using TdT-mediated dUTP nick end labeling (TUNEL), flow cytometry and transmission electron microscope (TEM). Its anti-tumor activity in vivo was verified in H22 ascitic fluid transfevent hepatocarcinoma of mice. 3-[4, 5-dimehyl-2-thiazolyl]-2, 5-di-phenyl-2H-tetrazolium bromide (MTT) assay and cell growth curve showed cell viability decrease with the 19peptide.Survival hepatocarcinoma cell decreased with time. In the treatment group, obvious change of apoptosis, the appearance of sub-Gl phase and dyed brown cells were seen by transmission electron microscope (TEM), flow cytometry and TdT-mediated dUTP nick end labeling (TUNEL), The inhibition rate of mouse H22 ascitic fluid transfevent hepatocarcinoma growth was 48.46%. As a whole, 19peptide could directly inhibit hepatocarcinoma cell proliferation and promote hepatocarcinoma cell apoptosis.
出处 《生物工程学报》 CAS CSCD 北大核心 2008年第1期68-73,共6页 Chinese Journal of Biotechnology
基金 国家自然基金(No.30472035) 黑龙江省自然科学基金(No.TD2005-21) 黑龙江省教育厅自然基金(No.11511104)~~
关键词 肿瘤抑素 细胞增殖 细胞凋亡 肿瘤治疗 Tumstatin, cell proliferation, cell apoptosis, tumor therapy
  • 相关文献

参考文献7

  • 1Saus J, Wieslander J, Langeveld J P, et al. Identification of the goodpasture antigen as the alpha 3(Ⅳ) chain of collagen Ⅳ. J Biol Chem, 1988, 263(26): 13374-13380.
  • 2Maeshima Y, Colorado P C, Torre A, et al. Distinct anti- tumor properties of a type Ⅳ collagen domain derived from basement membrane. J Biol Chem, 2000, 275(28): 21340-21348.
  • 3Floquet N, Pasco S, Ramont L, et al.. The antitumor properties of the alpha3(Ⅳ)-(185-203) peptide from the NCl domain of type Ⅳ collagen (tumstatin) are conformation-dependent.J Biol Chem, 2004, 279(3): 2091-2100.
  • 4余琼,周凌云,林雪松,徐建永,王淑静,刘兴汉.重组人成骨生长肽的表达、纯化和活性的研究[J].中国生物化学与分子生物学报,2004,20(4):467-472. 被引量:14
  • 5王淑静,刘岩,林雪松,付雪,徐建永,刘兴汉.肿瘤抑素抗肿瘤相关肽的克隆及生物活性[J].中国生物化学与分子生物学报,2005,21(3):322-328. 被引量:6
  • 6Maeshima Y, Colorado P C, Kalluri R. Two RGD-independent alpha v beta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem, 2000, 275(31): 23745-23750.
  • 7Maeshima Y, Yerramalla UL, Dhanabal M, et al. Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis. J Biol Chem, 2001, 276(34): 31959-31968.

二级参考文献22

  • 1余琼,周凌云,林雪松,徐建永,王淑静,刘兴汉.重组人成骨生长肽的表达、纯化和活性的研究[J].中国生物化学与分子生物学报,2004,20(4):467-472. 被引量:14
  • 2Bab I, Gazit D, Chorev M, Muhlrad A, Shteyer A, Greenberg Z,Namdar M, Kahn A. HistoneH4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity. EMBO J, 1992,11(5): 1867 ~ 1873
  • 3Bab I A, Einhorn T A. Polypeptide factors regulating osteogensis and bone marrow repair. J Cell Biochem. 1994, 55(3) :358 - 365
  • 4Greenberg Z, Chorev M, Muhlrad A, Shteyer A, Namdar M, Mansur N, Bab I. Mitogenic action of osteogenic growth peptide(OGP): role of amino and carboxy-terminal regions and charge. Biochim Biophys Acta,1993,1178:273 ~ 280
  • 5Bakalkin G Y, Rakhmaniova A B, Akparow V K, Volodin A A,Ovchinnikov V V, Sarkisyam R A. Amino acid sequence pattern in the regulatory peptides. Int J Pept Protein Res, 1991,38 ( 6 ): 505 - 510
  • 6Perler F B, Davis G E, Deam G E, Gimble F S, Jack W E, Neff N, Noren C J, Thorner J, Belfort M. Protein splicing elements: inteins and exteinsa definition of terms and recommended nomenclature. Nucleic Acids Res,1994,22(7):125~127
  • 7Greenberg Z, Gavish H, Muhlrad A, Chorev M, Shteyer A, AttarNamdar M, Tartakovsky A, Bab I. Isolation of osteogenic growth peptide from osteoblastic MC3T3 El cell culutures anddemonstration of OGP binding proteins. J Cell Biochem, 1997,65:359 ~ 367
  • 8Gavish H, Bab I, Tartakovsky A, Chorev M, Mansur N, Greenberg Z,Nandar- Attar M. Humanalpha2-macroglobulin is an Osteogenic growth peptide-binding protein. Biochemistry, 1997,36:14883 - 14888
  • 9Bab I, Gavish H, Namdar-Attar M, Muhirad A, Greenberg Z, Chen Y, Mansur N, ShteyerA, Chorev M. Isolation of mitogenically active C terminal truncated pentapeptide of osteogenic growth peptide from human plasma and culture medium of murine osteoblastic cel
  • 10Gurevitch O, Slavin S, Muhlrad A, Shteyer A, Gazit D, Chorev M,Vidson M, Namdar- Attar M,Berger E, Bleiberg I, Bab. Osteogenic growth peptide increase blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice. Blood, 19

共引文献16

同被引文献21

  • 1付雪,王淑静,林雪松,刘兴汉.肿瘤抑素抗血管活性相关肽的表达及活性研究[J].医学分子生物学杂志,2005,2(3):157-161. 被引量:8
  • 2栗亚,刘兴汉,林雪松,马洪星,张宇雯,李冀宏,刘远莉,李丹.肿瘤抑素相关肽T42对人脐静脉内皮细胞和人胃腺癌细胞的抑制作用[J].中国组织工程研究与临床康复,2007,11(10):1837-1840. 被引量:4
  • 3袁丽杰,赵恒宇,苏晓杰.小分子肽-肿瘤抑素19肽纯化及抗肿瘤活性研究[J].现代生物医学进展,2007,7(5):674-676. 被引量:5
  • 4马洪星,粟亚,张宇雯,李冀宏,刘岩,刘远莉,李丹,刘兴汉.人肿瘤抑素相关T21RGD肽的表达与纯化[J].国际遗传学杂志,2007,30(3):169-172. 被引量:2
  • 5Maeshima Y, Colorado PC, Torre A, et al. Distinct antitumor properties of a type Ⅳ collagen domain derived from basement membrane [J]. Biol Chem, 2000, 275(28): 21340-21348.
  • 6Maeshima Y, Yerramalla UL, Dhanabal M, et al. Extraeellular matrixderived peptide binds to alpha (v)beta(3) integrin and inhibits angiogenesis [J]. J Biol Chem, 2001, 276 (34): 31959- 31968.
  • 7Hamano Y, Kalluri R. Tumstatin, the NC1 domain of alpha3 chain of type Ⅳ collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth [J]. Biochem Biophys Res Commun, 2005, 333 (2):292- 298.
  • 8Maeshima Y, Sudhakar A, Lively JC, et al. Tumstatin,an endothelial cellspecific inhibitor of protein synthesis[JJ. Science, 2002, 295(5552):140-143.
  • 9Hamano Y,Kalluri R.Tumstatin,the NC1 domain of alpha3chain of type Ⅳ collagen,is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.Biochem Biophys Res,2005,333:292-298.
  • 10Maeshima Y,Sudhakar A,Lively JC,et al.Tumstatin,an endothelial cell-specific inhibitor of protein synthesis.Science,2002,295:140-143.

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部